The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 101–200 of 1,010
Cai, L.-M., Lyu, X.-M., Luo, W.-R., Cui, X.-F., Ye, Y.-F., Yuan, C.-C., Peng, Q.-X., Wu, D.-H., Liu, T.-F., Wang, E., et al. (2015) · Oncogene · doi:10.1038/onc.2014.341 · Cited by 199
The emerging multiple roles of nuclear Akt
Martelli, A. M., Tabellini, G., Bressanin, D., Ognibene, A., Goto, K., Cocco, L., & Evangelisti, C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.017 · Cited by 198
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis
Yuan, L., Lv, Y., Li, H., Gao, H., Song, S., Zhang, Y., Xing, G., Kong, X., Wang, L., Li, Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3218 · Cited by 197
Long Non-coding RNAs and their Role in Metastasis
WEIDLE, U. H., BIRZELE, F., KOLLMORGEN, G., & RÜGER, R. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20027 · Cited by 196
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
Wang, Z., & Wu, X. (2020) · Cancer Medicine · doi:10.1002/cam4.3410 · Cited by 195
The tumor suppressor PTEN has a critical role in antiviral innate immunity
Li, S., Zhu, M., Pan, R., Fang, T., Cao, Y.-Y., Chen, S., Zhao, X., Lei, C.-Q., Guo, L., Chen, Y., et al. (2016) · Nature Immunology · doi:10.1038/ni.3311 · Cited by 195
Li, W., Dong, X., He, C., Tan, G., Li, Z., Zhai, B., Feng, J., Jiang, X., Liu, C., Jiang, H., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1177-0 · Cited by 195
Balanced mTORC1 Activity in Oligodendrocytes Is Required for Accurate CNS Myelination
Lebrun-Julien, F., Bachmann, L., Norrmen, C., Trotzmuller, M., Kofeler, H., Ruegg, M. A., Hall, M. N., & Suter, U. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1105-14.2014 · Cited by 190
Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses
Kitagishi, Y., Kobayashi, M., Kikuta, K., & Matsuda, S. (2012) · Depression Research and Treatment · doi:10.1155/2012/752563 · Cited by 191
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
Luongo, F., Colonna, F., Calapà, F., Vitale, S., Fiori, M. E., & De Maria, R. (2019) · Cancers · doi:10.3390/cancers11081076 · Cited by 189
Wang, Z.-F., Liao, F., Wu, H., & Dai, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1181-4 · Cited by 185
Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty
Badowski, C., He, B., & Garmire, L. X. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00283-7 · Cited by 183
Gomez-Rodriguez, J., Wohlfert, E. A., Handon, R., Meylan, F., Wu, J. Z., Anderson, S. M., Kirby, M. R., Belkaid, Y., & Schwartzberg, P. L. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131459 · Cited by 180
Neuronal SUMOylation: Mechanisms, Physiology, and Roles in Neuronal Dysfunction
Henley, J. M., Craig, T. J., & Wilkinson, K. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00008.2014 · Cited by 182
Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects
Ahmed, S., Khan, H., Aschner, M., Mirzae, H., Küpeli Akkol, E., & Capasso, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165622 · Cited by 182
IQGAPs choreograph cellular signaling from the membrane to the nucleus
Smith, J. M., Hedman, A. C., & Sacks, D. B. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.005 · Cited by 181
Wang, L., Cho, Y.-L., Tang, Y., Wang, J., Park, J.-E., Wu, Y., Wang, C., Tong, Y., Chawla, R., Zhang, J., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0056-0 · Cited by 180
Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines
Liang, W., Chen, X., Zhang, S., Fang, J., Chen, M., Xu, Y., & Chen, X. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00246-5 · Cited by 180
IGFBP2: integrative hub of developmental and oncogenic signaling network
Li, T., Forbes, M. E., Fuller, G. N., Li, J., Yang, X., & Zhang, W. (2020) · Oncogene · doi:10.1038/s41388-020-1154-2 · Cited by 175
Bi, X., Lv, X., Liu, D., Guo, H., Yao, G., Wang, L., Liang, X., & Yang, Y. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-00222-3 · Cited by 176
Elucidating Human Phosphatase-Substrate Networks
Li, X., Wilmanns, M., Thornton, J., & Köhn, M. (2013) · Science Signaling · doi:10.1126/scisignal.2003203 · Cited by 171
Role of microRNAs in breast cancer
Singh, R., & Mo, Y.-Y. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23296 · Cited by 173
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
Bezzi, M., Seitzer, N., Ishikawa, T., Reschke, M., Chen, M., Wang, G., Mitchell, C., Ng, C., Katon, J., Lunardi, A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4463 · Cited by 172
Self-citationWang, L., Zhou, K., Fu, Z., Yu, D., Huang, H., Zang, X., & Mo, X. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0872-y · Cited by 172
Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer
Jeong, S.-H., Kim, H.-B., Kim, M.-C., Lee, J.-M., Lee, J. H., Kim, J.-H., Kim, J.-W., Park, W.-Y., Kim, S.-Y., Kim, J. B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95802 · Cited by 172
STAT3 regulated ARF expression suppresses prostate cancer metastasis
Pencik, J., Schlederer, M., Gruber, W., Unger, C., Walker, S. M., Chalaris, A., Marié, I. J., Hassler, M. R., Javaheri, T., Aksoy, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms8736 · Cited by 170
PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
Lee, M.-S., Jeong, M.-H., Lee, H.-W., Han, H.-J., Ko, A., Hewitt, S. M., Kim, J.-H., Chun, K.-H., Chung, J.-Y., Lee, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms8769 · Cited by 171
Niu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 170
Sarkar, S., Dubaybo, H., Ali, S. S., Goncalves, P. H., Kollepara, S. L. S., Sethi, S. N., Philip, P. A., & Li, Y. (2013) · Europe PMC (PubMed Central) · Cited by 170
Brain Endothelial Cells Maintain Lactate Homeostasis and Control Adult Hippocampal Neurogenesis
Wang, J., Cui, Y., Yu, Z., Wang, W., Cheng, X., Ji, W., Guo, S., Zhou, Q., Wu, N., Chen, Y., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.09.009 · Cited by 165
An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer
Maertens, O., & Cichowski, K. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.04.002 · Cited by 167
Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer
Bollu, L. R., Mazumdar, A., Savage, M. I., & Brown, P. H. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0934 · Cited by 168
Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease
Matsuda, S., Kobayashi, M., & Kitagishi, Y. (2013) · ISRN Endocrinology · doi:10.1155/2013/472432 · Cited by 165
Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
Lim, H. J., Crowe, P., & Yang, J.-L. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1803-3 · Cited by 166
mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
Jung, S. H., Hwang, H. J., Kang, D., Park, H. A., Lee, H. C., Jeong, D., Lee, K., Park, H. J., Ko, Y.-G., & Lee, J.-S. (2019) · Oncogene · doi:10.1038/s41388-018-0521-8 · Cited by 166
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Fusco, N., Sajjadi, E., Venetis, K., Gaudioso, G., Lopez, G., Corti, C., Guerini Rocco, E., Criscitiello, C., Malapelle, U., & Invernizzi, M. (2020) · Genes · doi:10.3390/genes11070719 · Cited by 166
mTOR signaling in tumorigenesis
Xu, K., Liu, P., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.007 · Cited by 165
Neddylation of PTEN regulates its nuclear import and promotes tumor development
Xie, P., Peng, Z., Chen, Y., Li, H., Du, M., Tan, Y., Zhang, X., Lu, Z., Cui, C.-P., Liu, C. H., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00443-z · Cited by 164
Functions and Regulation of the PTEN Gene in Colorectal Cancer
Molinari, F., & Frattini, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2013.00326 · Cited by 162
Autistic-Like Traits and Cerebellar Dysfunction in Purkinje Cell PTEN Knock-Out Mice
Cupolillo, D., Hoxha, E., Faralli, A., De Luca, A., Rossi, F., Tempia, F., & Carulli, D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.339 · Cited by 162
Insulin/IGF1 Signaling Inhibits Age-Dependent Axon Regeneration
Byrne, A. B., Walradt, T., Gardner, K. E., Hubbert, A., Reinke, V., & Hammarlund, M. (2014) · Neuron · doi:10.1016/j.neuron.2013.11.019 · Cited by 157
What Is Known about Breast Cancer in Young Women?
Zhu, J. W., Charkhchi, P., Adekunte, S., & Akbari, M. R. (2023) · Cancers · doi:10.3390/cancers15061917 · Cited by 225
The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration
Yang, L., Miao, L., Liang, F., Huang, H., Teng, X., Li, S., Nuriddinov, J., Selzer, M. E., & Hu, Y. (2014) · Nature Communications · doi:10.1038/ncomms6416 · Cited by 157
Nakahata, S., Ichikawa, T., Maneesaay, P., Saito, Y., Nagai, K., Tamura, T., Manachai, N., Yamakawa, N., Hamasaki, M., Kitabayashi, I., et al. (2014) · Nature Communications · doi:10.1038/ncomms4393 · Cited by 158
Schultz, K. A. P., Rednam, S. P., Kamihara, J., Doros, L., Achatz, M. I., Wasserman, J. D., Diller, L. R., Brugières, L., Druker, H., Schneider, K. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0629 · Cited by 158
Mitochondrial ROS-derived PTEN oxidation activates PI3K pathway for mTOR-induced myogenic autophagy
Kim, J. H., Choi, T. G., Park, S., Yun, H. R., Nguyen, N. N. Y., Jo, Y. H., Jang, M., Kim, J., Kim, J., Kang, I., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0165-9 · Cited by 166
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
Deken, M. A., Gadiot, J., Jordanova, E. S., Lacroix, R., van Gool, M., Kroon, P., Pineda, C., Geukes Foppen, M. H., Scolyer, R., Song, J.-Y., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1238557 · Cited by 153
Alexander, M. S., Casar, J. C., Motohashi, N., Vieira, N. M., Eisenberg, I., Marshall, J. L., Gasperini, M. J., Lek, A., Myers, J. A., Estrella, E. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73579 · Cited by 154
Xia, T., Chen, S., Jiang, Z., Shao, Y., Jiang, X., Li, P., Xiao, B., & Guo, J. (2015) · Scientific Reports · doi:10.1038/srep13445 · Cited by 153
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Hashemi, M., Etemad, S., Rezaei, S., Ziaolhagh, S., Rajabi, R., Rahmanian, P., Abdi, S., Koohpar, Z. K., Rafiei, R., Raei, B., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114204 · Cited by 167
Wu, C., Xue, Y., Wang, P., Lin, L., Liu, Q., Li, N., Xu, J., & Cao, X. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302379 · Cited by 156
Yonemori, K., Kurahara, H., Maemura, K., & Natsugoe, S. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.59 · Cited by 159
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
Bazzichetto, C., Conciatori, F., Pallocca, M., Falcone, I., Fanciulli, M., Cognetti, F., Milella, M., & Ciuffreda, L. (2019) · Cancers · doi:10.3390/cancers11040435 · Cited by 164
Conley‐LaComb, M. K., Saliganan, A. D., Kandagatla, P., Chen, Y. Q., Cher, M. L., & Chinni, S. R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-85 · Cited by 149
CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy
Cai, J., Li, R., Xu, X., Zhang, L., Lian, R., Fang, L., Huang, Y., Feng, X., Liu, X., Xu, L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0065-8 · Cited by 156
Zheng, L., Liang, H., Zhang, Q., Shen, Z., Sun, Y., Zhao, X., Gong, J., Hou, Z., Jiang, K., Wang, Q., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01495-y · Cited by 159
MC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Cao, J., Wan, L., Hacker, E., Dai, X., Lenna, S., Jimenez-Cervantes, C., Wang, Y., Leslie, N. R., Xu, G. X., Widlund, H. R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.010 · Cited by 144
Targeting PI3K Signaling in Combination Cancer Therapy
Tostivint, E. P., Thibault, B., & Guillermet‐Guibert, J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.04.002 · Cited by 156
PI3K/Akt/mTOR inhibitors in breast cancer.
Lee, J. J. X., Loh, K. W.-J., & Yap, Y. S. (2015) · PubMed · doi:10.7497/j.issn.2095-3941.2015.0089 · Cited by 142
Taverna, S., Giallombardo, M., Pucci, M., Flugy, A., Manno, M., Raccosta, S., Rolfo, C., De Leo, G., & Alessandro, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4204 · Cited by 139
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
Garber, S. T., Hashimoto, Y., Weathers, S.-P., Xiu, J., Gatalica, Z., Verhaak, R. G. W., Zhou, S., Fuller, G. N., Khasraw, M., de Groot, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now132 · Cited by 139
Brito, M. B., Goulielmaki, E., & Papakonstanti, E. A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00166 · Cited by 162
Dhar, S., Kumar, A., Li, K., Tzivion, G., & Levenson, A. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.11.004 · Cited by 146
The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor
McLaughlin, S. K., Olsen, S. N., Dake, B., De Raedt, T., Lim, E., Bronson, R. T., Beroukhim, R., Polyak, K., Brown, M., Kuperwasser, C., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.004 · Cited by 135
SIRF: Quantitative in situ analysis of protein interactions at DNA replication forks
Roy, S., Luzwick, J. W., & Schlacher, K. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201709121 · Cited by 144
MicroRNA‐17∼92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways
Jin, H. Y., Oda, H., Lai, M., Skalsky, R. L., Bethel, K. J., Shepherd, J., Kang, S. G., Liu, W., Sabouri-Ghomi, M., Cullen, B. R., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.178 · Cited by 146
PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation
Gupta, A., Anjomani-Virmouni, S., Koundouros, N., Dimitriadi, M., Choo-Wing, R., Valle, A., Zheng, Y., Chiu, Y.-H., Agnihotri, S., Zadeh, G., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.019 · Cited by 134
Sun, Y., Zhang, H., Meng, J., Guo, F., Ren, D., Wu, H., & Jin, X. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111194 · Cited by 152
Szymonowicz, K., Oeck, S., Malewicz, N. M., & Jendrossek, V. (2018) · Cancers · doi:10.3390/cancers10030078 · Cited by 145
PTEN ceRNA networks in human cancer
Poliseno, L., & Pandolfi, P. P. (2015) · Methods · doi:10.1016/j.ymeth.2015.01.013 · Cited by 141
Self-citationMove Over, Bacteria! Viruses Make Their Mark as Mutualistic Microbial Symbionts
Roossinck, M. J. (2015) · Journal of Virology · doi:10.1128/jvi.02974-14 · Cited by 131
Turning Off AKT: PHLPP as a Drug Target
Newton, A. C., & Trotman, L. C. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140338 · Cited by 128
Nuclear PI3K signaling in cell growth and tumorigenesis
Davis, W. J., Lehmann, P. Z., & Li, W. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00024 · Cited by 138
di Meo, N. A., Lasorsa, F. M., Rutigliano, M., Milella, M., Ferro, M., Battaglia, M., Ditonno, P., & Lucarelli, G. T. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2195553 · Cited by 157
Surviving change: the metabolic journey of hematopoietic stem cells
Kohli, L., & Passegué, E. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.001 · Cited by 128
LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells
Guo, C., Song, W.-Q., Sun, P., Jin, L. H., & Dai, H.-Y. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0213-4 · Cited by 132
PTEN is a protein tyrosine phosphatase for IRS1
Shi, Y., Wang, J., Chandarlapaty, S., Cross, J. R., Thompson, C. B., Rosen, N. X., & Jiang, X. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2828 · Cited by 140
MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma
Tu, K., Liu, Z., Yao, B., Han, S., & Yang, W. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3309 · Cited by 128
Gifford, C. C., Tang, J., Costello, A., Khakoo, N. S., Nguyen, T. Q., Goldschmeding, R., Higgins, P. J., & Samarakoon, R. (2021) · Clinical Science · doi:10.1042/cs20201213 · Cited by 133
Guo, S., Ye, H., Teng, Y., Wang, Y.-L., Yang, G., Li, X.-B., Zhang, C., Yang, X., Yang, Z., & Yang, X. Y. (2013) · Nature Communications · doi:10.1038/ncomms3544 · Cited by 129
Takeuchi, K., Gertner, M. J., Zhou, J., Parada, L. F., Bennett, M. V. L., & Zukin, R. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222803110 · Cited by 123
Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif
Hamilton, M. P., Rajapakshe, K., Hartig, S. M., Reva, B. A., McLellan, M. D., Kandoth, C., Ding, L., Zack, T. I., Gunaratne, P. H., Wheeler, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3730 · Cited by 132
Scott, W. J., Hentemann, M. F., Rowley, R. B., Bull, C. O., Jenkins, S., Bullion, A. M., Johnson, J. S., Redman, A. M., Robbins, A. H., Esler, W. P., et al. (2016) · ChemMedChem · doi:10.1002/cmdc.201600148 · Cited by 129
A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children
Hansen‐Kiss, E., Beinkampen, S., Adler, B. M., Frazier, T. W., Prior, T. W., Erdman, S. H., Eng, C., & Herman, G. E. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104484 · Cited by 127
Vanadium Compounds as PTP Inhibitors
Irving, E., & Stoker, A. W. (2017) · Molecules · doi:10.3390/molecules22122269 · Cited by 129
Huang, X., Liu, C., Kong, N., Xiao, Y., Yurdagul, A., Tabas, I., & Tao, W. (2022) · Nature Protocols · doi:10.1038/s41596-021-00665-4 · Cited by 123
Zhao, H., Wang, J., & To, S. S. T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3052 · Cited by 140
Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
Cocco, S., Piezzo, M., Calabrese, A., Cianniello, D., Caputo, R., Lauro, V. D., Fusco, G., Gioia, G. D., Licenziato, M., & Laurentiis, M. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134579 · Cited by 137
Miao, L., Yang, L., Huang, H., Liang, F., Ling, C., & Hu, Y. (2016) · eLife · doi:10.7554/elife.14908 · Cited by 121
Pten is necessary for the quiescence and maintenance of adult muscle stem cells
Yue, F., Bi, P., Wang, C., Shan, T., Nie, Y., Ratliff, T. L., Gavin, T. P., & Kuang, S. (2017) · Nature Communications · doi:10.1038/ncomms14328 · Cited by 121
Carbognin, L., Miglietta, F., Paris, I., & Dieci, M. V. (2019) · Cancers · doi:10.3390/cancers11091401 · Cited by 123
Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review
Al-Koussa, H., El-Mais, N., Maalouf, H., Abi‐Habib, R. J., & El‐Sibai, M. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01232-9 · Cited by 120
Autophagy in Human Health and Disease: Novel Therapeutic Opportunities
Giampieri, F., Afrin, S., Forbes-Hernández, T. Y., Gasparrini, M., Cianciosi, D., Reboredo‐Rodríguez, P., Varela‐López, A., Quiles, J. L., & Battino, M. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7234 · Cited by 121
PTEN Interacts with Histone H1 and Controls Chromatin Condensation
Chen, Z. H., Zhu, M., Yang, J., Liang, H., He, J., He, S., Wang, P., Kang, X., McNutt, M. A., Yin, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.008 · Cited by 117
Jhanwar‐Uniyal, M., Amin, A. G., Cooper, J., Das, K., Schmidt, M. H., & Murali, R. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.12.001 · Cited by 128
Tian, L., Fang, Y., Xue, J., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075885 · Cited by 120
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012518 · Cited by 119
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
Saito, S., Zhuang, Y., Shan, B., Danchuk, S. D., Luo, F., Korfei, M., Günther, A., & Lasky, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186615 · Cited by 127
PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease
Li, Y., Hu, Q., Li, C., Liang, K., Xiang, Y., Hsiao, H. H.-Y., Nguyen, T. K., Park, P. K., Egranov, S. D., Ambati, C. R., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121987 · Cited by 125
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
Ouyang, P., Wang, L., Wu, J., Tian, Y., Chen, C., Li, D., Yao, Z., Chen, R., Xiang, G., Gong, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1344272 · Cited by 137
“PTEN ’ s expression is regulated through diverse mechanisms, including epigenetic silencing, post-transcriptional and post-translational modi fi cations, and protein-protein interactions (108).”
Background
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.